Samsara BioCapital as of Dec. 31, 2024
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 43 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp (SRRK) | 33.3 | $243M | 5.6M | 43.22 | |
| Cargo Therapeutics (CRGX) | 8.7 | $64M | 4.4M | 14.42 | |
| Septerna (SEPN) | 8.7 | $63M | 2.8M | 22.90 | |
| Mineralys Therapeutics (MLYS) | 8.6 | $63M | 5.1M | 12.31 | |
| Neurogene (NGNE) | 5.4 | $39M | 1.7M | 22.86 | |
| Upstream Bio (UPB) | 5.0 | $36M | 2.2M | 16.44 | |
| Lenz Therapeutics (LENZ) | 3.9 | $29M | 987k | 28.87 | |
| Alumis (ALMS) | 3.5 | $26M | 3.3M | 7.86 | |
| Arcellx Common Stock (ACLX) | 2.7 | $20M | 254k | 76.69 | |
| Zymeworks Del (ZYME) | 2.0 | $15M | 1.0M | 14.64 | |
| Jasper Therapeutics Com New (JSPR) | 1.7 | $13M | 585k | 21.38 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 1.4 | $10M | 968k | 10.51 | |
| Rhythm Pharmaceuticals (RYTM) | 1.3 | $9.7M | 173k | 55.98 | |
| Nkarta (NKTX) | 1.3 | $9.4M | 3.8M | 2.49 | |
| Contineum Therapeutics Cl A (CTNM) | 1.2 | $8.6M | 589k | 14.65 | |
| Palvella Therapeutics Inc Ne (PVLA) | 1.1 | $8.2M | 680k | 12.00 | |
| Acelyrin | 1.1 | $7.9M | 2.5M | 3.14 | |
| Onkure Therapeutics Com Cl A (OKUR) | 1.0 | $7.1M | 824k | 8.60 | |
| Leap Therapeutics Com New (LPTX) | 1.0 | $7.0M | 2.4M | 2.88 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.9 | $6.2M | 850k | 7.32 | |
| Aclaris Therapeutics (ACRS) | 0.8 | $5.9M | 2.4M | 2.48 | |
| Gossamer Bio (GOSS) | 0.8 | $5.5M | 6.1M | 0.90 | |
| Eliem Therapeutics (CLYM) | 0.6 | $4.7M | 2.6M | 1.80 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $4.5M | 98k | 46.44 | |
| Inozyme Pharma (INZY) | 0.6 | $4.3M | 1.6M | 2.77 | |
| Sutro Biopharma (STRO) | 0.6 | $4.0M | 2.2M | 1.84 | |
| Artiva Biotherapeutics (ARTV) | 0.4 | $2.9M | 292k | 10.08 | |
| Vtv Therapeutics Cl A New (VTVT) | 0.4 | $2.9M | 207k | 13.81 | |
| Tango Therapeutics (TNGX) | 0.3 | $1.9M | 630k | 3.09 | |
| Day One Biopharmaceuticals I (DAWN) | 0.3 | $1.9M | 147k | 12.67 | |
| Immatics SHS (IMTX) | 0.2 | $1.4M | 198k | 7.11 | |
| Prime Medicine (PRME) | 0.2 | $1.2M | 405k | 2.92 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $1.1M | 202k | 5.54 | |
| Hillevax | 0.1 | $827k | 400k | 2.07 | |
| Curis (CRIS) | 0.1 | $607k | 198k | 3.06 | |
| Janux Therapeutics (JANX) | 0.1 | $603k | 11k | 53.54 | |
| Bolt Biotherapeutics | 0.1 | $561k | 1.0M | 0.54 | |
| Lyra Therapeutics | 0.1 | $406k | 2.0M | 0.21 | |
| Allakos | 0.0 | $208k | 172k | 1.21 | |
| Kronos Bio | 0.0 | $74k | 78k | 0.95 | |
| Allovir (ALVR) | 0.0 | $35k | 82k | 0.42 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $31k | 133k | 0.23 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.1k | 100k | 0.02 |
